openPR Logo

Press Releases from SMi Group (888 total)

MHRA Exclusive Speaker Interview Released and ImmuneBiotech AB CEO Announced as …

SMi Reports: In the run up to Immuno-Oncology 2018, SMi announces the conference’s newest session led by ImmuneBiotech AB, as well as an exclusive speaker interview with the MHRA. There’s just over 1 week to go until SMi’s Immuno-Oncology conference on 26th – 27th September 2018 in London, UK (http://www.immuno-oncology-conference.com/openpr), set to bring together an unrivalled gathering of industry leaders and scientific pioneers to explore the potential of targeted immuno-therapies. A new

Pharma Giants Collaboration Accelerates Access to Rare Disease Treatment – Hea …

With only 4 weeks to go until SMi's 8th annual conference on Orphan Drugs & Rare Diseases (http://www.orphandrugs.co.uk/openpr), places are becoming increasingly limited and potential attendees are urged to book soon to take advantage of the exclusive opportunity of meeting and networking with a host of internationally renowned organisations to learn about the recent advances made in rare disease treatments. Recently in rare disease industry news, seven pharmaceutical companies have announced

Exclusive Interview with Richard Cole, Chairman at Social Media in the Defence S …

SMi Group caught up with the conference chairman for the 8th annual Social Media in the Defence & Military Sector, Richard Cole, Director at I3 Gen, who has exclusively shared his interview with you prior to the conference. Richard Cole is a Strategic Communications Consultant specialising in the Prevention and Countering of Violent Extremism (P/CVE) and Defence Engagement. With 23 years of military experience, including a decade in Public Affairs and

Senior U.S. Military: U.S. DoD, U.S. Air Force, US Marine Corps, DISA and DARPA …

With President Donald Trump advocating Congress to allocate $8 billion over the next five years to establish a “U.S. Space Force” as the sixth branch of the military, there has never been a better time to meet and discuss the future of military satellite communications. US Vice President Mike Pence: “The time has come to establish the United States Space Force. It’s not enough to have an American presence in space,

Achieving Controlled Nucleation During Aseptic Lyophilization

Controlled nucleation is essential for obtaining high-quality lyophilized products with intra- and inter-batch consistency. Two approaches to achieving controlled nucleation have been investigated recently: creating a pressure differential and using an ice fog to insert seed crystals into the vials within the lyophilization chamber. Morrisa Jones, Senior Scientist, Vaccine Drug Product Development Merck, who is speaking at the SMi’s Groups’ Lyophilization USA Conference she will be comparing and contrasting two

Lieutenant General Anderson, Deputy Chief of Staff G3/5/7, US Army to Deliver Br …

SMi Group Reports: Lieutenant General Joseph Anderson will present at the Defence Safety Conference on the 1st and 2nd October in London Lieutenant General Joseph Anderson, Deputy Chief of Staff G3/5/7, US Army has confirmed his participation at the Defence Safety Conference, taking place in London, United Kingdom on the 1st and 2nd October 2018. He will be briefing on: ‘The Importance of Safety in Enhancing Us Army Operational Capability’ Covering: • The cost

MHRA, Pfizer, Autolus and Tusk Theraputics Sign Up for Immuno-Oncology Conferenc …

SMi Reports: Industry leaders MHRA, Pfizer, Autolus, Tusk Therapeutics, KCL, Boehringer Ingelheim and more are amongst the latest organisations to register for Immuno-Oncology 2018 (http://www.immuno-oncology-conference.com/openpr) There’s just 2 weeks until SMi’s Immuno-Oncology conference commences in London on the 26th and 27th September. With limited places left, interested attendees are urged to book soon to avoid missing out on joining an international gathering of immuno-therapy experts at this highly-anticipated conference. Recent Confirmed Attendees

Agenda released - Pharmaceutical Microbiology UK 2019 announces key industry spe …

SMi’s Pharma is proud to announce the 8th Annual Pharmaceutical Microbiology is back and this year the conference is taking place at the Copthorne Tara Hotel in London, UK on 21st and 22nd January 2019. Sponsored by: Gold Sponsor: DuPont and Sponsors: Mettler Toledo, Biomerieux and Copan Group Proud to announce the Co-Chairs for the conference James Drinkwater, Chairman, Pharmaceutical & Healthcare Sciences Society and Olivier Chancel, Sterility, and Aseptic

SMi’s 11th Annual Social Media in Pharma Returns to London this January 2019!

SMi is excited to present the return of their 11th annual Social Media in the Pharmaceutical Industry conference to London, UK on the 21st - 22nd January 2019! This year looks at opening the speaker line up to represent all industry stakeholders, from pharma to social media pioneers, all whilst keeping the patient at the forefront. The conference will explore the most recent advances in digital application within the pharmaceutical sector

6 Key Reasons to Attend the 13th Annual Sell-out Series on Energy From Waste

EfW Policy and The Waste Hierarchy: Don't miss the opening keynote from Dawn Woodward, Deputy Head, Resources and Waste, DEFRA, on the latest updates on England’s resource and waste strategy surrounding waste policy. The Department of Transport will be providing an in depth overview of the UK biofuels policy. To put this into an industry perspective, the Environmental Services Association will discuss whether the policy will deliver in reality. Case Studies:

GSK and Sanofi to present the opening sessions for the 13th annual conference

Day 1 - Opening Spotlight Session - Clinical Supply Chain: A New Recognized R&D Dimension Tackling R&D Challenges and Serving the Patients The Pharmaceutical Quality Group (PQG) issued a monograph on Pharmaceutical Distribution in 1997 and initiated planning to revise this in line with the new EU GDP regulatory guideline (a final revised version was issued in March 2013 with an effective date of 8 September 2013). Although the 2013 EU-GDP guidelines

Invitation from Carina Schey, Researcher at University of Groningen and Chair of …

SMi Reports: This year’s Orphan Drugs & Rare Diseases Conference Chair Carina Schey, Researcher at University of Groningen, has released a letter of invitation detailing the 8th annual event (http://www.orphandrugs.co.uk/openpr). SMi’s Orphan Drugs & Rare Diseases Conference is set to take place this year in London, UK on the 17th and 18th October. The two-day conference is in its 8th year and will be providing delegates with the unrivalled opportunity of

Queen's University Belfast and Santen to Present Opening Keynote this November!

Hear from Queen's University Belfast and Santen as they present the opening addresses this November. Day 1 – Opening Keynote Address: New Strategies for Treating Retinal Vascular Diseases Retinal vascular diseases are a leading cause of blindness in the Western world. Advancement in the clinical management of these diseases has been fast-paced, with new treatments becoming available as well as license extensions of existing treatments.* Discover advancements in the treatment of ocular diseases

Chief Executive for DE&S and 200 Senior Leaders to Attend the Defence Safety Con …

SMi Group Reports: The Defence Safety Conference will convene in London in just four weeks’ time. Organised by SMi Group and supported by the Defence Safety Authority, UK Ministry of Defence, The Defence Safety Conference, taking place Central London on the 1st and 2nd October, will address the broad spectrum of safety across Military Aviation, Land and Maritime. A limited number of seats have been made available for industry to attend

Leading Compliance Organisations to Present at Defence Exports Conference in Two …

With the defence trade regulatory environment ever-changing and increasingly complex, companies within the sector are continuing to improve their programmes and maintain compliance. The 13th annual Defence Exports Conference http://www.defence-exports.com/openpr, organised by SMi Group and taking place in Rome, Italy on the 19th and 20th September 2018, will have 13 key presentations that will highlight best practice for complying with export controls and regulations led by key industry accounts, including: • Day 2

Boeing, Airbus, JETEX, Viasat, JBT and Leonardo to deliver briefings at Military …

SMi Group has recently announced the agenda for its 19th annual Military Airlift and Air-to-Air Refuelling conference, taking place in Rome, Italy on the 4th and 5th December 2018. The programme and registration is now live on: http://www.military-airlift.com/openpr As Europe’s largest bespoke military airlift conference, this sell-out event promises to give comprehensive overview of strategic and tactical airlift capability in the region and offer allied programme managers the chance

Less than 4 Weeks until Immuno-Therapy Experts Gather at the Immuno-Oncology Con …

There’s just under 4 weeks until SMi’s Immuno-Oncology Conference commences in London on the 26th and 27th September (www.immuno-oncology-conference.com/openpr). The event aims to propagate thought-provoking discussions about the future of Immuno-Oncology between industry leaders, and update delegates on current key areas for development, advancements in therapy and revisions of regulations. The study of immuno-oncology has been ever-present in recent news, with biomarkers in melanoma having been recently identified by Dana-Farber Cancer Institute

6 Key Reasons to Attend the 13th Annual Sell-out Series on Energy From Waste

EfW Policy and The Waste Hierarchy: Don't miss the opening keynote from Dawn Woodward, Deputy Head, Resources and Waste, DEFRA, on the latest updates on England’s resource and waste strategy surrounding waste policy. The Department of Transport will be providing an in depth overview of the UK biofuels policy. To put this into an industry perspective, the Environmental Services Association will discuss whether the policy will deliver in reality. Case Studies:

13th Annual Sell-out Conference: Cold Chain Distribution 2018

The 13th annual Cold Chain Distribution Conference takes place this December on the 10th and 11th in London, UK. This year's conference will be exploring new technologies to provide a highly connected temperature-controlled logistics process, whilst remaining GDP compliant. With new regulations and certifications in place such as IATA's CEIV-Pharma Certification and HSA's GDP Certification. Here's a quick reminder on which key industry experts will be present: - [CHAIR] - Bob Hayes, Director,

the future of ocular gene editing is here at Ophthalmic Drugs 2018

SMi Group are delighted to welcome the expertise from a senior panel of big pharma and ophthalmic organisations, as well as regulatory bodies, at the 2nd annual Ophthalmic Drugs 2018 conference, taking place in November in the City of London, UK. Outstanding speaker line-up for 2018: The event will address the impact of the overwhelming digitalisation such as artificial intelligence in drug discovery and how companies, from biotech's to pharma, need to

Explore the latest developments in ATMPs at Cell & Gene Therapy 2018

SMi Group are delighted to welcome expertise from a senior panel of big pharma and biotech organisations and regulatory bodies, at the most talked about conference on Cell & Gene Therapy 2018 launching this October in the City of London, UK. Outstanding Speaker Line-up: The conference will be led by scientists and clinicians researching, developing and testing new treatments for genetically inherited and acquired diseases, using gene delivery technology, stem cell manipulation

Registration Opens for the 12th Annual Mobile Deployable Communications Conferen …

SMi Group is delighted to announce the 12th annual Mobile Deployable Communications conference, will take place in Warsaw on the 31st January and 1st February 2019. This highly anticipated event will explore key drivers causing the growing demand for flexible, protected, and interoperable CIS capabilities. Registration is now live! With the biggest Early Bird discount available until 28 September. Save £400 and secure your place now at: http://www.mobiledeployable.com/openpr With

Camcode Global Sign up to Sponsor Defence Exports Conference 2018

SMi Group is delighted to announce that the 13th annual conference on Defence Exports, taking place in Rome on the 19th and 20th September 2018, will be sponsored by: Deloitte LLP, OCR, Pillsbury and latest confirmed: Camcode Global. “Camcode Global is the most experienced unique identification (UID) service provider in the defence industry. We understand compliance marking technologies and standards reporting. We also know the best way to plan your

Event Highlights for 13th Annual Industry Leading Cold Chain Distribution 2018

Event Highlights for SMi's 13th Annual Cold Chain Distribution 2018 GS1 standard - a critical tool in the fight against counterfeiting - Glen Hodgson, Head of Healthcare, GS1 UK How the Air Cargo Industry is Improving the Handling of Pharmaceutical Shipments - Francisco Rizzuto, Cargo Specialist, Manager for Europe, IATA - + Panel Discussion Global Analysis and Management of Temperature Excursions - Gianne Olaes-Dénis, Supply Chain Quality Manager, Sanofi Genzyme Europe Protecting your products in the global

Insightful Developments and an Exclusive Interview from Roche

Keynote Speaker: David Silverman, Senior Clinical Director, Ophthalmology, Roche SMi are delighted to have interviewed our speaker David Silverman, Senior Clinical Director, Ophthalmology, Roche regarding his thoughts and experiences within the ophthalmology space. Snapshot: Q. What are the biggest developments in the ophthalmic drug industry, and how the future of ocular drug development? Check out the full interview in the download centre Roche’s phase III ophthalmology programme is expected to begin later in 2018 Roche announced

Your Exclusive Invitation from the Chair for Cell & Gene Therapy 2018

SMi are delighted to have Pamela Tranter, Head of Translational Research Group, UCL Chair the inaugural conference this October and also present the opportunities and challenges of translating cell and gene therapies in academia. Pamela has kindly written a message below about the Cell & Gene Therapy conference and what attendees can gain from the two day event. Quick Snapshot: This conference is another excellent opportunity to meet and network with experts and

Invitation from Dr James Legg, Vice President R&D at Crescendo Biologics, Chair …

SMi Reports: This year’s Immuno-Oncology Conference Chair James Legg, Vice President R&D at Crescendo Biologics, has released a letter of invitation detailing this year’s event. SMi’s Immuno-Oncology Conference is set to take place this year in London, UK on the 26th and 27th September (http://www.immuno-oncology-conference.com/openpr). The two-day conference will be providing delegates with the unrivalled learning opportunity of hearing from internationally renowned expert speakers giving their expertise and experiences in the

SMi’s Exclusive Interview with Abon Pharmaceuticals, Director just released

SMi Reports: An exclusive interview with Dr. Yanming Zu, Director at Abon Pharmaceuticals, who will be presenting an Opening Address on 'Challenges of lyophilized product development, in the run-up to the 4th annual Lyophilization USA Conference taking place 15th-16th November 2018, Iselin, New Jersey, USA. The two-day conference promises to provide a stimulating environment for delegates, with an impressive list of international industry experts from Pfizer, Amgen and Merck sharing

HealthTech Healx raise $10m to accelerate drug discovery, prior to speaking at O …

SMi Reports: AI HealthTech Company Healx, who raised $10m to advance drug discovery and treatments for rare diseases, are set to speak at the 8th Annual Orphan Drugs and Rare Diseases Conference in London (http://www.orphandrugs.co.uk/openpr). Healx, a HealthTech company based in Cambridge who are also set to speak at this year’s Orphan Drugs and Rare Diseases conference in October in London, have announced a $10m (£7.6m) Series A funding round. The

Women in SATCOM to discuss the National Defence Authorisation Act 2018 at Global …

SMi are delighted to announce that the 20th annual Global MilSatCom conference (http://www.globalmilsatcom.com/openpr), taking place 6th – 8th November in London, will feature a new, all female panel discussion on ‘What the National Defence Authorisation Act 2018 Means for SATCOM’. Led by senior military and industry representatives from the US, the panellists include: • Ms Deanna Ryals, Chief, International Programmes Division, Military Satellite Communications Systems (MILSATCOM) Directorate, Space and Missiles System Center (SMC),

An Interview with the Acting Chief of the Continental Movement Coordination Cent …

The 19th annual Military Airlift and Air-to-Air Refuelling conference and exhibition (http://www.military-airlift.com/openpr) will commence in Rome on the 4th and 5th December 2018. In the run up to the event, SMi Group have released an exclusive interview with Group Captain David Akrong, Acting Chief of the Continental Movement Coordination Centre, who will be presenting at the conference on: ‘How the Continental Movement Coordination Centre Is Building the Logistic Capability of African

Challenges facing Immuno-Oncology industry includes identifying patients before …

SMi Reports: This year’s Immuno-Oncology conference, taking place 26th - 27th September in London (http://www.immuno-oncology-conference.com/openpr), aims to address the issues and challenges burdening the industry, as well as the promising advancements made recently. Since the early 2000s, Immuno-Oncology has been making impressive advancements in using a patient's own immune system to overcome cancer. The exciting potential of cancer immunotherapies means that utilising the pre-existing immunity of cancer patients can result in

How challenges including Brexit, inadequate funding & insufficient patient sampl …

SMi Reports: 8th Annual Orphan Drugs and Rare Diseases Conference to bring together pharmaceutical companies, non-profit organisations and orphan drug developers to explore alliances and facilitate progress. Research into orphan drugs and rare diseases is facing challenges such as Brexit, lack of research, knowledge and experience, gaining funding, and assembling large enough sample sizes of affected patients in order to effectively study the diseases. The importance of collaboration between patient organisations,

2 New Case Studies from Cory Riverside Energy and Krakowski Holding Komunalny

Growing from strength to strength, SMi's 11th annual Energy from Waste conference is fast becoming the industry's leading platform to discuss critical updates in the everchanging EfW landscape. Our sell-out conference series has attracted a growing community of waste experts, public sector authorities and industry leaders all collaborating to facilitate the growing need for sustainable energy. This Week's Spotlight: Two Case Studies - Cory Riverside Energy and Krakowski Holding Komunalny S.A. Cory

IATA's CEIV-Pharma Certification or HSA's GDP Certification?

Players throughout the pharmaceutical supply chain are experiencing growing pressure to gain accreditation for handling the high-value, temperature-sensitive cargo, as having a certification becomes more commonplace, rather than an exceptional feat in the industry. There are currently 2 different measures of standards, one is IATA's CEIV-Pharma Certification and the other is HSA's GDP Certification. There are major players on both sides of the fence which hold – GDP-compliant certificates and CEIV-pharma certifications.

Industry news with an exclusive interview from Aerie Pharmaceuticals for Ophthal …

SMi are delighted to have interviewed Mitchell de Long, Vice President, Chemistry, Aerie Pharmaceuticals regarding his thoughts and experiences within the ophthalmology space. Mitchell A. (Mitch) deLong holds the position of Vice President, Chemistry at Aerie Pharmaceuticals as well as Adjunct Professor of Chemistry at Duke University. Since Mitch helped to found Aerie as a Duke University spinout in 2005, Aerie has filed 5 INDs and 2 NDAs, with its first

Talks from the MHRA, Innovate UK, Plasticell and more

The lengthening shadow of increase in health spending in the coming years is sharpening the minds of legislators, regulators and payers alike. The growing time-to-market, the rising costs in development of novel medicines, as well as the more basic drive to be ‘ahead of the game’, forces the industry and the legislators to rethink basic postulates of drug development. The global regulatory environment is undergoing major reshape, allowing patients early access

Newly Added Panel for SMi's 11th Annual Energy from Waste Conference with Talks …

SMi Group are thrilled to announce a new panel discussion which has been added onto the agenda for this year. Since registration officially opened a few weeks ago, Energy from Waste has received an overwhelming response from the industry wanting to get involved. Now even bigger and better, a newly added panel discussion has been added, discussing how both industry and government can create an environment that encourages and enables private

SMi’s Exclusive Interview with MedImmune Principal Scientist just released

An exclusive interview with Dr. Antonio DiGiandomenico, Principal Scientist, MedImmune has been released SMi Reports: An exclusive interview with Dr. Antonio DiGiandomenico, Principal Scientist at MedImmune on challenges and his vision for the future of AMR R&D has been released in the run-up to the 3rd annual Superbugs & Superdrugs USA Conference taking place in Iselin, New Jersey on November 12 - 13, 2018. SMi Group is proud to present some insightful

Royal Canadian Air Force, EU Training Mission Somalia and NATO SPA to present on …

SMi Group Reports: Three new presentations have been added to the 19th Annual Military Airlift and Air-to-Air Refuelling Conference agenda, taking place 3 – 5 December 2018 in Rome, Italy. Conference organisers, SMi Group are delighted to announce that three new presentations, led by Royal Canadian Air Force, EU Training Mission Somalia and NATO Support and Procurement Agency have been added to the three-day agenda for Military Airlift Air-to-Air Refuelling 2018. Taking

Royal Navy, US Navy, DSA, Swedish Armed Forces, Royal Australian Navy, US Marine …

The Defence Safety Conference http://www.defencesafety.com/openpr, taking place at the Copthorne Tara Hotel, Kensington, London on the 1st and 2nd October 2018, will feature high level briefings from senior leaders on maritime safety. Conference organisers SMi Group are delighted to announce that the following speakers will all share their organisations priorities, challenges and solutions when it comes to enhancing maritime safety for the future: • Vice Admiral Ben Key, Fleet Commander, Royal Navy • Rear Admiral

FDA releases Biosimilar Action Plan - Hear more at this year’s Biosimilars USA …

SMi Group Reports: Following the FDA’s release of a Biosimilar Action Plan, this year’s Biosimilars USA conference promises to explore the developments in biosimilar drug development As the world of biosimilars gains more traction and promise, and the FDA announces the release of a long-awaited Biosimilar Action Plan, SMi’s 5th Annual Biosimilars USA Conference, taking place in New Jersey, USA on the 14th and 15th November 2018, aims to give crucial

UK New Space Launch capability to be discussed at Global MilSatCom 2018

Growing launch capability remains critical to continue delivering effective communications in the era of small satellites within the increasingly congested 4th domain. With the UK leading in small satellite sector, growing emphasis is being placed on new launch sites, this is evidenced by recent announcements for new funding for a spaceport in Scotland and Cornwall Spaceport’s collaboration with Virgin Orbit to deliver horizontal launch capacity in the South of England. SMi

Optimization of Lyophilization and alternatives to conventional Freeze-Drying me …

SMi Group reports: Alina Alexeenko of Purdue University presenting LyoHub's overview and strategies for the future of lyophilization and alternatives to conventional methods Optimization of Lyophilization is the quest for the industry. The process of lyophilization is used to stabilize products susceptible to physical and chemical degradation, and is often time-consuming, expensive, and has an energy efficiency of less than 5 percent. The rise of biologics, which are heavily reliant on

Hear from the Department of Transport and CNIM

Check out the agenda for what is shaping up to be SMi's best Energy from Waste programme to date. Secure your attendance early and stay at the forefront of new regulations, cutting edge developments in plant technology, solutions to your funding needs and network with our growing global community of waste experts, public sector authorities and industry leaders. This Week's Spotlight: Department of Transport and CNIM New for 2018: UK biofuels policy:

The long road to vaccination by the MSF

Did you know; since November 2016, MSF teams have treated more than 41,000 children for measles in Maniema, Lomami, Tanganyika, Ituri, South Kivu, and Equateur provinces As measles sweeps across Democratic Republic of Congo (DRC), more than one million children have been vaccinated against the disease in a nine-month campaign by Médecins Sans Frontières (MSF - known as Doctors Without Borders), supporting the Ministry of Health. For those who suffer complications

Gene Therapy bringing new hope to patients and families

Top Story: Gene Therapy bringing new hope to patients and families “Still tear up now thinking about it, just knowing that your daughter is not going to be able to see…” recalled by Ryan Troxel when he found out that his daughter, Molly Troxel, had an inherited genetic disease that led to her early childhood blindness. At the time of the diagnosis, there was no cure for the condition. But thanks

SMi’s Cell & Gene Therapy: Targeting Solid & Liquid Malignancies with the Same …

The Cell & Gene Therapy industry has been the most talked about department within R&D, with various technological advancements introduced to date. Hear about the latest developments of advanced therapy medicinal products (ATMPs) during the Cell & Gene Therapy 2018 conference taking place this October in the City of London, UK. Latest News: CAR T Cells Show Solid Progress: Finding (and hitting) the right target can be difficult. “The antigens that are present

W. J. Wiess and A.S. Lynch invitation to SMi’s Superbugs & Superdrugs USA Conf …

SMi Group reports: William J. Weiss - University of North Texas Health Science Center and Anthony Simon Lynch - Janssen supporting SMi's Superbugs & Superdrugs USA Conference, which is due to take place this November in New Jersey William and Anthony are chairing SMi's Superbugs & Superdrugs USA Conference and encourage all involved in AMR to join experts from multiple disciplines, in the field of infectious disease representing research, regulatory, funding,

Exploring the recent PQG / ECA guide to GDP

The Pharmaceutical Quality Group (PQG) issued a monograph on Pharmaceutical Distribution in 1997 and initiated planning to revise this in line with the new EU GDP regulatory guideline (a final revised version was issued in March 2013 with an effective date of 8 September 2013). Although the 2013 EU-GDP guidelines provide far more details than previous guidelines, it is clear that there was and is a need for further guidance on

Go To Page:    1 2 3 4 5 6 7 8 9 10